Gene · 6872
Papers2,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemoselective Tagging of Protein Methacrylation. | J Am Chem Soc | 2025 | 41218107 | PubTator, text mining | PubMed |
| DeepEPI: CNN-transformer-based model for extracting TF interactions through predicting enhancer-promoter interactions. | Bioinform Adv | 2025 | 41031058 | PubTator, text mining | PubMed |
| Key genetic determinants of diabetes remission in patients with obesity following bariatric surgery. | Updates Surg | 2025 | 40993333 | PubTator, text mining | PubMed |
| Mechanistic insights into DNA binding by BD1 of the TAF1 tandem bromodomain module. | Biochem J | 2025 | 40928734 | PubTator, text mining | PubMed |
| Exploring the uncharted role of cell senescence in rare diseases. | Orphanet J Rare Dis | 2025 | 40890826 | PubTator, text mining | PubMed |
| Activation of CISD2 as a protective strategy against doxorubicin-induced cardiotoxicity. | Redox Biol | 2025 | 40876442 | PubTator, text mining | PubMed |
| Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4-TAF6 axis in the cell cycle. | Cell Death Dis | 2025 | 40846851 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| An in-silico pan-cancer bulk and single-cell profiling of transcription factors in protein autoubiquitination. | Discov Oncol | 2025 | 40591126 | PubTator, text mining | PubMed |
| NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β-TrCP1/FBXO5 Axis. | Adv Sci (Weinh) | 2025 | 40577599 | PubTator, text mining | PubMed |
| A screen of chromatin-targeting compounds identifies TAF1 as a novel regulator of HIV latency. | bioRxiv | 2025 | 40475469 | PubTator, text mining | PubMed |
| PROTAC-Mediated Degradation of TAF1 Induces Apoptosis in AML Cells and Inhibits Tumor Growth In Vivo. | Mol Cancer Ther | 2025 | 40376796 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| Genetic insight into lung neuroendocrine tumors: Notch and Wnt signaling pathways as potential targets. | J Transl Med | 2025 | 40361150 | PubTator, text mining | PubMed |
| Conformational and Functional Regulation of SET by Legumain Cleavage. | J Mol Biol | 2025 | 40187686 | PubTator, text mining | PubMed |
| Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. | PLoS One | 2025 | 40153395 | PubTator, text mining | PubMed |
| Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and Mutation. | Am J Surg Pathol | 2025 | 39760648 | PubTator, text mining | PubMed |
| Harnessing the TAF1 Acetyltransferase for Targeted Acetylation of the Tumor Suppressor p53. | Adv Sci (Weinh) | 2025 | 39716936 | PubTator, text mining | PubMed |
| Genetic alterations are related to clinicopathological features and risk of recurrence/metastasis of hepatocellular carcinoma. | Eur J Cancer Prev | 2025 | 39642087 | PubTator, text mining | PubMed |
| OSI-027 as a Potential Drug Candidate Targeting Upregulated Hub Protein TAF1 in Potential Mechanism of Sinonasal Squamous Cell Carcinoma: Insights from Proteomics and Molecular Docking. | Biology (Basel) | 2024 | 39765756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6872/papers?page=3